{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:20:34Z","timestamp":1769552434669,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute of Neurological Disorders and Stroke of the National Institutes of Health","award":["NIH NINDS P50 NS16308"],"award-info":[{"award-number":["NIH NINDS P50 NS16308"]}]},{"name":"MacMillan Gift Fund (University of Minnesota)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.eplepsyres.2018.07.015","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T11:07:20Z","timestamp":1539428840000},"page":"115-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Iron supplements in nursing home patients associated with reduced carbamazepine absorption"],"prefix":"10.1016","volume":"147","author":[{"given":"Jae Eun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Praneeth R.","family":"Bathena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine M.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilo E.","family":"Leppik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela K.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10928-005-0083-6","article-title":"Inherent correlation between dose and clearance in therapeutic drug monitoring settings: possible misinterpretation in population pharmacokinetic analyses","volume":"32","author":"Ahn","year":"2005","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-2007-979609","article-title":"Carbamazepine clinical pharmacology: a review","volume":"28","author":"Albani","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1528-1157.2003.62202.x","article-title":"Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data","volume":"44","author":"Battino","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/01.WNL.0000052997.43492.E0","article-title":"Variability of total phenytoin serum concentrations within elderly nursing home residents","volume":"60","author":"Birnbaum","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2007.08.004","article-title":"Carbamazepine dose-concentration relationship in elderly nursing home residents","volume":"77","author":"Birnbaum","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0035","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.0000000000003629","article-title":"Prevalence of epilepsy\/seizures as a comorbidity of neurologic disorders in nursing homes","volume":"88","author":"Birnbaum","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2710.2006.00717.x","article-title":"Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage","volume":"31","author":"Bondareva","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2125.1991.tb05525.x","article-title":"Iron supplements: a common cause of drug interactions","volume":"31","author":"Campbell","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00007691-199508000-00006","article-title":"Validation of a quick modeling program generating clearance estimates at steady state for routine therapeutic drug monitoring","volume":"17","author":"el Battah","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2710.2011.01296.x","article-title":"Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients","volume":"37","author":"El Desoky","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0060","first-page":"293","article-title":"Iron binding to anticonvulsants","volume":"15","author":"Garzon-de la Mora","year":"1984","journal-title":"Arch. Invest. Med. (Mex)"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/j.1875-9114.1998.tb03853.x","article-title":"Population pharmacokinetics of carbamazepine in adults with epilepsy","volume":"18","author":"Graves","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2710.2004.00557.x","article-title":"Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data","volume":"29","author":"Jiao","year":"2004","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0080","first-page":"693","article-title":"Established antiepileptic drugs","volume":"5","author":"Perucca","year":"1996","journal-title":"Baillieres Clin. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/FTD.0b013e31824d6a4e","article-title":"Population pharmacokinetics of carbamazepine in elderly patients","volume":"34","author":"Punyawudho","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011569703060","article-title":"Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults","volume":"28","author":"Reith","year":"2001","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","article-title":"Clinically significant pharmacokinetic drug interactions with carbamazepine","volume":"31","author":"Spina","year":"1996","journal-title":"An update. Clin Pharmacokinet"},{"key":"10.1016\/j.eplepsyres.2018.07.015_bib0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2125.1984.tb02397.x","article-title":"Impaired enzyme induction by rifampicin in the elderly","volume":"17","author":"Twum-Barima","year":"1984","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118300871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118300871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:41:03Z","timestamp":1760276463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121118300871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":20,"alternative-id":["S0920121118300871"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.07.015","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron supplements in nursing home patients associated with reduced carbamazepine absorption","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}